UBS Group
FFTY icon

UBS Group’s CapForce IBD 50 ETF FFTY Stock Holding History

UBS Group’s Portfolio FFTY Stock Details FFTY Fund Activity
Bought
Maintained
Sold
Quarter Market Value Status Shares Change in
Stake 		Trade Value Portfolio Weight Portfolio Position
2026
Q1 		$107K Sell
3,214
-10,356
-76% -$385K ﹤0.01% 6970
2025
Q4 		$472K Buy
13,570
+10,056
+286% +$371K ﹤0.01% 6114
2025
Q3 		$131K Buy
3,514
+2,767
+370% +$95.7K ﹤0.01% 6941
2025
Q2 		$24.3K Hold
747
– – ﹤0.01% 8311
2025
Q1 		$20.1K Sell
747
-1,290
-63% -$37.8K ﹤0.01% 8235
2024
Q4 		$58.2K Sell
2,037
-1,124
-36% -$32.7K ﹤0.01% 7203
2024
Q3 		$85K Sell
3,161
-1,792
-36% -$47.2K ﹤0.01% 6468
2024
Q2 		$138K Sell
4,953
-632
-11% -$17.2K ﹤0.01% 5940
2024
Q1 		$154K Buy
5,585
+213
+4% +$5.57K ﹤0.01% 6020
2023
Q4 		$131K Sell
5,372
-1,817
-25% -$41.3K ﹤0.01% 6034
2023
Q3 		$161K Sell
7,189
-3,200
-31% -$77.3K ﹤0.01% 5517
2023
Q2 		$266K Sell
10,389
-5,749
-36% -$136K ﹤0.01% 5282
2023
Q1 		$382K Sell
16,138
-1,017
-6% -$23.4K ﹤0.01% 4905
2022
Q4 		$374K Sell
17,155
-1,424
-8% -$35.1K ﹤0.01% 4946
2022
Q3 		$454K Sell
18,579
-7,378
-28% -$204K ﹤0.01% 4419
2022
Q2 		$697K Sell
25,957
-10,604
-29% -$341K ﹤0.01% 4016
2022
Q1 		$1.43M Buy
36,561
+2,328
+7% +$90.3K ﹤0.01% 3756
2021
Q4 		$1.57M Buy
34,233
+1,366
+4% +$65.2K ﹤0.01% 3958
2021
Q3 		$1.56M Buy
32,867
+1,166
+4% +$54.5K ﹤0.01% 3804
2021
Q2 		$1.47M Sell
31,701
-12,667
-29% -$574K ﹤0.01% 3845
2021
Q1 		$1.95M Buy
44,368
+9,606
+28% +$436K ﹤0.01% 3587
2020
Q4 		$1.43M Sell
34,762
-2,454
-7% -$95.7K ﹤0.01% 3720
2020
Q3 		$1.39M Sell
37,216
-32,118
-46% -$1.18M ﹤0.01% 3399
2020
Q2 		$2.39M Sell
69,334
-16,110
-19% -$500K ﹤0.01% 2708
2020
Q1 		$2.39M Sell
85,444
-123,366
-59% -$4.11M ﹤0.01% 2588
2019
Q4 		$7.25M Sell
208,810
-54,133
-21% -$1.83M ﹤0.01% 2234
2019
Q3 		$8.48M Buy
262,943
+46,573
+22% +$1.59M ﹤0.01% 1900
2019
Q2 		$7.42M Sell
216,370
-19,260
-8% -$649K ﹤0.01% 1995
2019
Q1 		$7.9M Sell
235,630
-60,299
-20% -$1.9M ﹤0.01% 1846
2018
Q4 		$8.17M Sell
295,929
-278,967
-49% -$8.65M ﹤0.01% 1733
2018
Q3 		$22.1M Buy
574,896
+73,403
+15% +$2.7M 0.01% 1139
2018
Q2 		$17.6M Buy
501,493
+258,122
+106% +$9M 0.01% 1269
2018
Q1 		$8.11M Sell
243,371
-58,340
-19% -$1.99M ﹤0.01% 1882
2017
Q4 		$10M Buy
301,711
+249,952
+483% +$8.3M ﹤0.01% 1713
2017
Q3 		$1.64M Buy
51,759
+13,007
+34% +$385K ﹤0.01% 3299
2017
Q2 		$1.05M Buy
38,752
+3,776
+11% +$101K ﹤0.01% 3572
2017
Q1 		$896K Buy
34,976
+2,076
+6% +$51.9K ﹤0.01% 3626
2016
Q4 		$794K Sell
32,900
-19,085
-37% -$446K ﹤0.01% 3744
2016
Q3 		$1.23M Buy
51,985
+20,218
+64% +$464K ﹤0.01% 3275
2016
Q2 		$683K Sell
31,767
-2,306
-7% -$48.6K ﹤0.01% 3664
2016
Q1 		$720K Sell
34,073
-64,371
-65% -$1.3M ﹤0.01% 3508
2015
Q4 		$2.18M Buy
98,444
+97,060
+7,013% +$2.22M ﹤0.01% 2712
2015
Q3 		$30K Buy
+1,384
New +$33K ﹤0.01% 6286

Other funds holding FFTY

CPA
Clear Point Advisors Melville, New York $129M AUM 12.02% 1-Year Est. Return
Susquehanna International Group
Susquehanna International Group Bala Cynwyd, Pennsylvania $893B AUM 36.07% 1-Year Est. Return
IWM
IHT Wealth Management Chicago, Illinois $4.3B AUM 21.02% 1-Year Est. Return
Goldman Sachs
Goldman Sachs New York $871B AUM 31.28% 1-Year Est. Return
Citadel Advisors
Citadel Advisors Miami, Florida $618B AUM 30.34% 1-Year Est. Return
CFP
Comprehensive Financial Planning East Petersburg, Pennsylvania $144M AUM 25.61% 1-Year Est. Return
BNP Paribas Financial Markets
BNP Paribas Financial Markets Paris, France $206B AUM 31.61% 1-Year Est. Return
TRCT
Tower Research Capital (TRC) New York $3.85B AUM 32.11% 1-Year Est. Return
Bank of America
Bank of America Charlotte, North Carolina $1.37T AUM 24.88% 1-Year Est. Return
DSCM
Del-Sette Capital Management Schenectady, New York $167M AUM 38.06% 1-Year Est. Return

UBS Group's FFTY Position: Q1 2026 in Review

UBS Group reduced its CapForce IBD 50 ETF (FFTY) stake by 76% in Q1 2026, selling an estimated $385K and leaving 3,214 shares worth $107K. The position accounts for ﹤0.01% of the portfolio, ranked #6970.

UBS Group first reported a position in FFTY in Q3 2015 and has held it in 43 quarters since. The position peaked at $22.1M in Q3 2018. 39 funds tracked by Wall St. Rank hold FFTY as of Q1 2026.

  • UBS Group held 3,214 shares of CapForce IBD 50 ETF worth $107K as of Q1 2026.
  • UBS Group sold 10,356 CapForce IBD 50 ETF shares in Q1 2026, an estimated $385K.
  • CapForce IBD 50 ETF made up ﹤0.01% of UBS Group's portfolio in Q1 2026, its #6970 holding.
  • UBS Group first reported a position in CapForce IBD 50 ETF in Q3 2015 and has held it in 43 quarters since.
  • UBS Group's CapForce IBD 50 ETF position peaked at $22.1M in Q3 2018.
  • 39 funds tracked by Wall St. Rank held CapForce IBD 50 ETF as of Q1 2026.

Based on UBS Group's 13F filing for Q1 2026, filed 5 May 2026.